Invention Grant
US09387237B2 Methods of treating a patient having an autoimmune disorder by administering a soluble BCMA
有权
通过施用可溶性BCMA治疗患有自身免疫疾病的患者的方法
- Patent Title: Methods of treating a patient having an autoimmune disorder by administering a soluble BCMA
- Patent Title (中): 通过施用可溶性BCMA治疗患有自身免疫疾病的患者的方法
-
Application No.: US14449564Application Date: 2014-08-01
-
Publication No.: US09387237B2Publication Date: 2016-07-12
- Inventor: Susan Kalled , Sambasiva Rao
- Applicant: Biogen Idec MA Inc.
- Applicant Address: US MA Cambridge
- Assignee: BIOGEN MA INC.
- Current Assignee: BIOGEN MA INC.
- Current Assignee Address: US MA Cambridge
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K39/00 ; A61K38/17 ; C07K16/22 ; C07K16/18
Abstract:
Therapeutic regimens for administration of BAFF antagonists for treatment of immunologic and related disorders are described. Regimens involve a short-term BAFF antagonist administration course followed by an extended no-treatment period prior the round of administration.
Public/Granted literature
- US20150098953A1 METHODS OF TREATING A PATIENT HAVING AN AUTOIMMUNE DISORDER BY ADMINISTERING A BAFF ANTAGONIST Public/Granted day:2015-04-09
Information query
IPC分类:
